1. Antithrombotics and PAD: A New Paradigm in Practice

3. Program Goals

4. PAD Is More Than a Disease of the Extremities

5. Prevalence of PAD

6. Risk Factors for PAD

8. Detecting PAD

9. AHA/ACC Guidelines: Antiplatelet Agents

10. PAD: Aspirin and Clopidogrel

11. EUCLID: Primary Efficacy Endpoint

12. COMPASS: Trial Design

13. COMPASS: Primary Endpoint CV Death, Stroke, MI

14. COMPASS: Major Bleeding

15. COMPASS: Net Clinical Benefit, Mortality

16. COMPASS: Limb Outcomes

17. COMPASS: Reduction in Amputations

18. From CURE to COMPASS

19. COMPASS: Who Will Benefit?

20. VOYAGER PAD: Study Design

21. Abbreviations

22. Abbreviations (cont)